Hexcel Corp.
Congress has disclosed 6 buys and 8 sells of HXL (Hexcel Corp.) in official financial disclosures, each linked to its original filing. A transparency record — not investment advice.
Activity Congressional Activity
Fundamentals · FY2026 Valuation
Standard valuation multiples from SEC-reported GAAP financials (trailing twelve months), each compared to the median for —. We use reported GAAP, not forward or adjusted earnings, so our figures can sit higher than sites that do — especially for companies with falling profit. Relative context — not a target price or investment advice.
how it's calculated
how it's calculated
how it's calculated
14 trades Recent Congressional Trades
Two things to watch per trade: the disclosure lag (how many days passed before the trade was made public) and the price move in that window (how the stock moved during those non-public days). A sell followed by a price drop, or a buy followed by a rise, means well-timed trading — visible here in the open. Note: the Score measures how notable a trade is, not whether it made money — the price move is shown for context and isn't part of it.
| Politician | Chamber | Type | Owner | Date | Disclosure lag | Price move in that window | Amount | Score | Source |
|---|---|---|---|---|---|---|---|---|---|
| Jonathan Jackson | House | SELL ◆ insider divergence · strong | Joint · Morgan Stanley Trust Account | 2024-04-24 | 12 days | — | $15K–$50K 1.1% of NW |
84.4 | ↗ filing |
| Lois Frankel | House | SELL | Self | 2022-02-10 | 16 days | — | $1K–$15K 0.3% of NW |
6.8 | ↗ filing |
| Sara Jacobs | House | SELL | Self | 2021-04-09 | 32 days | — | $15K–$50K <0.1% of NW |
90.9 | ↗ filing |
| Lois Frankel | House | BUY | Self | 2021-02-25 | 0 days | — | $1K–$15K 0.3% of NW |
8.6 | ↗ filing |
| Lois Frankel | House | BUY | Self | 2020-12-03 | 0 days | — | $1K–$15K 0.3% of NW |
10.6 | ↗ filing |
| Lois Frankel | House | SELL | Self | 2020-10-29 | 0 days | — | $1K–$15K 0.3% of NW |
15.7 | ↗ filing |
| Lois Frankel | House | SELL | Self | 2020-10-27 | 0 days | — | $1K–$15K 0.3% of NW |
22.3 | ↗ filing |
| Susie Lee | House | SELL | Joint | 2020-08-05 | 27 days | — | $1K–$15K 0.2% of NW |
10.6 | ↗ filing |
| Lois Frankel | House | BUY | Self | 2020-06-09 | 0 days | — | $1K–$15K 0.3% of NW |
52.4 | ↗ filing |
| Susie Lee | House | BUY | Joint | 2020-06-05 | 26 days | — | $1K–$15K 0.2% of NW |
26.5 | ↗ filing |
| Susie Lee | House | SELL | Joint | 2020-04-06 | 25 days | — | $1K–$15K 0.2% of NW |
22.3 | ↗ filing |
| Susie Lee | House | BUY | Joint | 2019-11-11 | 20 days | — | $1K–$15K 0.2% of NW |
40.4 | ↗ filing |
| Susie Lee | House | SELL | Joint | 2019-03-14 | 18 days | — | $1K–$15K 0.2% of NW |
75.9 | ↗ filing |
| Lois Frankel | House | BUY | Self | 2018-12-10 | 0 days | — | $1K–$15K 0.3% of NW |
75.9 | ↗ filing |
Corporate insiders · SEC Form 4 Insider Activity
What the company's own officers and directors did in HXL — open-market purchases and sales from SEC Form 4 filings (option exercises, grants and tax withholding are excluded). This is context for the congressional activity above, never a buy/sell signal, and the two datasets are kept separate on purpose. Does convergence mean anything? →
Of the congressional trades in HXL, 0 coincided with corporate insiders moving the same way within 60 days, and 1 with insiders moving the opposite way. This is co-occurrence only — whether it carries any edge is tested honestly on the convergence page.
| Date | Insider | Role | Type | Size | Source |
|---|---|---|---|---|---|
| 2026-10-26 | KEATING NEAL J. | Director | BUY | $242K | ↗ EDGAR |
| 2026-09-03 | Lehman Gail E | Other | SELL | $813K | ↗ EDGAR |
| 2026-09-03 | Lehman Gail E | Other | SELL | $461K | ↗ EDGAR |
| 2026-08-14 | Fitzsimons Gina | Other | SELL | $363K | ↗ EDGAR |
| 2026-08-14 | Fitzsimons Gina | Other | SELL | $635K | ↗ EDGAR |
| 2026-02-27 | Evans Amy S | Other | SELL | $139K | ↗ EDGAR |
| 2025-10-29 | Winterlich Patrick | C-suite | SELL | $250K | ↗ EDGAR |
| 2025-10-27 | Smith Lyndon John | Other | SELL | $152K | ↗ EDGAR |
| 2025-09-02 | Fitzsimons Gina | Other | SELL 10b5-1 | $59K | ↗ EDGAR |
| 2025-08-28 | Merlot Thierry | Other | SELL 10b5-1 | $224K | ↗ EDGAR |
| 2025-08-28 | Merlot Thierry | Other | SELL 10b5-1 | $345K | ↗ EDGAR |
| 2024-08-30 | Merlot Thierry | Other | SELL 10b5-1 | $253K | ↗ EDGAR |
| 2024-08-30 | Merlot Thierry | Other | SELL 10b5-1 | $355K | ↗ EDGAR |
| 2024-08-28 | Lehman Gail E | Other | SELL | $304K | ↗ EDGAR |
| 2024-05-03 | Suever Catherine A | Director | BUY | $27K | ↗ EDGAR |
| 2024-05-01 | Gentile Tom | C-suite | BUY | $521K | ↗ EDGAR |
| 2024-05-01 | Gentile Tom | C-suite | BUY | $472K | ↗ EDGAR |
| 2024-04-29 | HACHEY GUY C | Director | BUY | $194K | ↗ EDGAR |
| 2024-04-29 | HACHEY GUY C | Director | BUY | $129K | ↗ EDGAR |
| 2024-04-26 | Stanage Nick L | C-suite | BUY | $964K | ↗ EDGAR |
| 2024-04-26 | EGNOTOVICH CYNTHIA M | Director | BUY | $258K | ↗ EDGAR |
| 2024-04-25 | CAMPBELL JEFFREY C | Director | BUY | $641K | ↗ EDGAR |
| 2024-02-14 | Fitzsimons Gina | Other | SELL 10b5-1 | $62K | ↗ EDGAR |
| 2024-02-09 | Merlot Thierry | Other | SELL | $322K | ↗ EDGAR |
| 2023-07-27 | Lehman Gail E | Other | SELL | $110K | ↗ EDGAR |
Combined timeline — Congress & insiders
Both sets of trades on one timeline, newest first, so you can see when they lined up. Congress vs ◆ insider.
| Date | Who | Type | Size | |
|---|---|---|---|---|
| ◆ insider | 2026-10-26 | KEATING NEAL J. Director | BUY | $242K |
| ◆ insider | 2026-09-03 | Lehman Gail E Other | SELL | $813K |
| ◆ insider | 2026-09-03 | Lehman Gail E Other | SELL | $461K |
| ◆ insider | 2026-08-14 | Fitzsimons Gina Other | SELL | $363K |
| ◆ insider | 2026-08-14 | Fitzsimons Gina Other | SELL | $635K |
| ◆ insider | 2026-02-27 | Evans Amy S Other | SELL | $139K |
| ◆ insider | 2025-10-29 | Winterlich Patrick C-suite | SELL | $250K |
| ◆ insider | 2025-10-27 | Smith Lyndon John Other | SELL | $152K |
| ◆ insider | 2025-09-02 | Fitzsimons Gina Other 10b5-1 | SELL | $59K |
| ◆ insider | 2025-08-28 | Merlot Thierry Other 10b5-1 | SELL | $224K |
| ◆ insider | 2025-08-28 | Merlot Thierry Other 10b5-1 | SELL | $345K |
| ◆ insider | 2024-08-30 | Merlot Thierry Other 10b5-1 | SELL | $253K |
| ◆ insider | 2024-08-30 | Merlot Thierry Other 10b5-1 | SELL | $355K |
| ◆ insider | 2024-08-28 | Lehman Gail E Other | SELL | $304K |
| ◆ insider | 2024-05-03 | Suever Catherine A Director | BUY | $27K |
| ◆ insider | 2024-05-01 | Gentile Tom C-suite | BUY | $521K |
| ◆ insider | 2024-05-01 | Gentile Tom C-suite | BUY | $472K |
| ◆ insider | 2024-04-29 | HACHEY GUY C Director | BUY | $194K |
| ◆ insider | 2024-04-29 | HACHEY GUY C Director | BUY | $129K |
| ◆ insider | 2024-04-26 | Stanage Nick L C-suite | BUY | $964K |
| ◆ insider | 2024-04-26 | EGNOTOVICH CYNTHIA M Director | BUY | $258K |
| ◆ insider | 2024-04-25 | CAMPBELL JEFFREY C Director | BUY | $641K |
| Congress | 2024-04-24 | Jonathan Jackson | SELL | $15K–$50K |
| ◆ insider | 2024-02-14 | Fitzsimons Gina Other 10b5-1 | SELL | $62K |
FAQ Common questions
How much has Congress traded HXL?
6 disclosed buys and 8 sells of HXL (Hexcel Corp.) appear in official congressional financial disclosures.
Is it legal for members of Congress to trade HXL?
Members of Congress may trade stocks but must disclose it under the STOCK Act. QuantCapitol tracks those public disclosures for transparency — nothing here is an accusation of wrongdoing or investment advice.
Where does this data come from?
Official US House Clerk and Senate electronic financial disclosures. Every trade links back to its original filing so you can verify it yourself.